Horvath clock CpGs in nine tumor types: coordinated methylation programs, not a uniform age shift
In nine TCGA cancer types, Horvath clock CpGs in tumors showed no consistent mean shift in age acceleration but far greater variance; analyzed as coordinated programs, some were linked to survival. This is an abstract; the full text was not reviewed. [1]
Automatic summary · not editorially reviewed
The key findings
Across nine TCGA cancer types, tumors showed no consistent mean shift in Horvath age acceleration relative to normal tissue, but about an order of magnitude more variance. [1]
PCA-derived tumor methylation programs captured 34.9%–50.8% of clock-CpG variance and produced 15 nominal survival associations, four significant after FDR correction. [1]
In external validation in GSE72308, two of three TCGA-nominated BRCA survival associations reproduced in the same protective direction. [1]
The source at a glance
- Study type / format
- Abstract of a multi-cancer methylation analysis with external validation
- Population / context
- Tumor and normal tissue samples from nine TCGA cancer types, plus external validation samples in GSE72308.
- Summary based on
- Study abstract
- Publication status
- Preprint · peer-review status not confirmed
- Original publication
- June 3, 2026
Clock CpGs across nine TCGA cancer types
The authors questioned a common assumption in clock analyses: that tumors move along the same methylation-aging axis as normal tissue, with clock CpGs read as single aging values. They tested this using Horvath clock CpGs across nine cancer types from The Cancer Genome Atlas (TCGA). Tumors did not show a consistent mean shift in Horvath age acceleration relative to normal tissue. Instead, age-acceleration variance was about an order of magnitude higher.
Supporting source [1]
Scalar clock summaries versus coordinated tumor programs
As survival biomarkers, single clock summaries produced zero nominal associations after adjustment for age, sex and stage. The authors therefore analyzed the clock CpGs as a coordinated methylation system. Principal component analysis (PCA)-derived tumor methylation programs captured 34.9%–50.8% of clock-CpG variance across cancers, and this structure persisted after adjustment for tumor purity, proliferative history and global methylation instability. In fully adjusted Cox models, the programs produced 15 nominal survival associations, four of which remained significant after false discovery rate (FDR) correction.
Supporting source [1]
Pathway links and external BRCA validation
Survival-associated programs were linked to transcriptional pathway activity, including unfolded protein response (UPR), epithelial-mesenchymal transition (EMT), interferon-gamma (IFN-γ) response and stemness, in directions consistent with their survival effects. The programs persisted after controlling for tumor-normal differentially methylated regions, so average cancer-associated methylation shifts did not explain them. In external validation in GSE72308, two of three TCGA-nominated BRCA survival associations reproduced in the same protective direction. These are associations, not evidence of cause.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The analysis covers nine TCGA cancer types, and external validation was limited to GSE72308 with two of three BRCA associations reproduced. The reported survival links are associations, not causal effects, and no clinical use is established.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Gande P, Kao A, Mokhashi O, Li WT, Ongkeko WM. · europepmc.org · June 3, 2026